Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction [Phase 2]
Phase 2 clinical trial evaluating pirfenidone for treatment of myocardial fibrosis following acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial). [Phase 4]
A Phase 4 trial update on de-prescribing beta blockers after coronary artery bypass graft surgery, investigating safety/efficacy implication…
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: AMI-DC in Patients With Anterior Wall Myocardial Infarction [Phase 1, Phase 2]
A phased clinical trial update is reported for AMI-DC in patients with anterior wall myocardial infarction (Phase 1/Phase 2).
-
FDA approval · 2022-09-16FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approves a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, pertaining to the approved generic prod…
-
FDA approval · 2022-09-12FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries’ supplemental application for clopidogrel bisulfate, indicating regulatory approval of change…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction [Phase 2, Phase 3]
Clinical trial update for sitagliptin plus G-CSF in acute myocardial infarction (Phase 2/3) has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction [Phase 2]
A Phase 2 clinical trial assessing safety and efficacy of Thymosin Beta 4 in patients with acute myocardial infarction has been completed.
-
FDA approval · 2022-07-21FDA Approved: VALSARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for VALSARTAN from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction [Phase 4]
Phase 4 clinical trial update evaluating Suxiao Jiuxin Pill for stabilization of vulnerable plaque in acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS [Phase 3]
A Phase 3 trial comparing ticagrelor 60 mg versus ticagrelor 90 mg in elderly patients with acute coronary syndrome has completed recruitmen…
-
FDA approval · 2022-06-30FDA Approved: RAMIPRIL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for ramipril submitted by Zydus Lifesciences Limited under ANDA078832.
-
FDA approval · 2022-06-29FDA Approved: ENALAPRIL MALEATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approves the original generic application for enalapril maleate (Enalapril) manufactured by Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Stem Cell in Acute Myocardial Infarction [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating stem cell therapy for acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction [Phase 2]
Phase 2 clinical trial investigating paroxetine-mediated GRK2 inhibition to reduce cardiac remodeling after acute myocardial infarction has …
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism [Phase 4]
A Phase 4 clinical trial comparing atorvastatin and pitavastatin for their effect on HbA1c in patients with acute myocardial infarction and …
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Digital Flu Intervention for People With Cardiovascular Conditions [NA]
A completed clinical trial evaluating a digital flu intervention for people with cardiovascular conditions, with results posted in 2022.
-
FDA approval · 2022-03-31FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a ge…
-
EMA approval · 2022-03-17EMA Authorised: Integrilin (eptifibatide) — GlaxoSmithKline Trading Services Limited
Authorised by EMA: Integrilin (eptifibatide) approved for unstable angina and myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Vascular Effects of Alirocumab in Acute MI-Patients [Phase 3]
Phase 3 trial update evaluating vascular effects of alirocumab in acute myocardial infarction patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome [Phase 4]
A Phase 4 trial comparing low molecular weight heparin (LMWH) to rivaroxaban in Chinese patients hospitalized with acute coronary syndrome e…
-
FDA approval · 2022-02-15FDA Approved: HEPARIN SODIUM — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for Heparin Sodium submitted by Sandoz Inc., indicating an additional regulatory action on this gene…
-
CLINICAL_TRIALS research · 2022-02-14Clinical Trial Update: Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study. [Phase 4]
A Phase 4 trial investigating how impaired gastric emptying during the acute phase of myocardial infarction affects the efficacy of oral ant…
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Optimal Dosage of Ticagrelor in Korean Patients With AMI [Phase 4]
A Phase 4 trial update investigating the optimal dosage of ticagrelor in Korean patients with acute myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly [NA]
The trial evaluated implantable cardioverter-defibrillator implantation in elderly patients with cardiomyopathy and coronary artery disease,…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction [Phase 2]
Phase 2 safety study of allogeneic mesenchymal precursor cell infusion in patients with acute myocardial infarction has completed with resul…